⏳ Fetching live dividend data...
Home › Calculator › HGENQ Dividend Calculator 2026
Humanigen, Inc. · OTC
Price: $0.00 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in HGENQ → $1.0010004501200205e+38M in 10 years · $8,340,836,334,033,435,000,000,000,000,000,000,000,000,000.00/month
Humanigen, Inc., a clinical-stage biopharmaceutical company, focuses on preventing and treating an immune hyper-response. The company is developing lenzilumab, an antibody that binds to and neutralizes granulocyte-macrophage colony-stimulating factor (GM-CSF), to treat cytokine storm associated with COVID-19 for which it has completed a Phase 3 study and is the focus of a Phase 2/3 study sponsored by the NIH. It is also developing lenzilumab, which is associated with CD19-targeted CAR-T cell therapies, as well as exploring the effectiveness of lenzilumab in other inflammatory conditions, such as acute Graft versus Host Disease in patients undergoing allogeneic hematopoietic stem cell transplantation and in eosinophilic asthma, and rheumatoid arthritis. In addition, the company focuses on studying lenzilumab for patients with chronic myelomonocytic leukemia exhibiting RAS pathway mutations. Its pipeline also includes two other Humaneered monoclonal antibodies, ifabotuzumab, which binds to EphA3, and HGEN005, which targets EMR1, as well as treats a range of eosinophilic diseases, including eosinophilic leukemia as an optimized naked antibody and as the backbone for a novel CAR-T construct. Humanigen, Inc. was incorporated in 2000 and is headquartered in Short Hills, New Jersey. On January 3, 2024, Humanigen, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime.
Ready to invest? Open HGENQ position with:
Real after-tax yield depends on where you live and how you hold HGENQ.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 1000000.00% | 999997.20% | $100,000,000 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 850000.00% | 849997.20% | $85,000,000 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 800000.00% | 799997.20% | $80,000,000 / yr |
| 🇬🇧 UK ISA | 0% | 1000000.00% | 999997.20% | $100,000,000 / yr |
| 🇬🇧 UK Taxable | 8.75% | 912500.00% | 912497.20% | $91,250,000 / yr |
| 🇨🇦 TFSA | 0% | 1000000.00% | 999997.20% | $100,000,000 / yr |
| 🇨🇦 CA Taxable | 25% | 750000.00% | 749997.20% | $75,000,000 / yr |
| 🇦🇺 Super (pension) | 15% | 850000.00% | 849997.20% | $85,000,000 / yr |
| 🇦🇺 AU Taxable | 30% | 700000.00% | 699997.20% | $70,000,000 / yr |
| 🇩🇪 DE Taxable | 26.375% | 736250.00% | 736247.20% | $73,625,000 / yr |
| 🇫🇷 FR Taxable | 30% | 700000.00% | 699997.20% | $70,000,000 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
HGENQ pays quarterly — 4 times per year. Next ex-div: TBD.
How HGENQ compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for HGENQ sourced from FMP /financial-growth endpoint — real data, not estimates.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the HGENQ dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →